Amanda Pereira da Cruz, Gloria Martins, Camila Marinelli Martins, Victoria Marques, Samantha Christovam, Denise Battaglini, Chiara Robba, Paolo Pelosi, Patricia Rieken Macedo Rocco, Fernanda Ferreira Cruz, Cynthia Dos Santos Samary, Pedro Leme Silva
BACKGROUND: Non-invasive respiratory support (conventional oxygen therapy [COT], non-invasive ventilation [NIV], high-flow nasal oxygen [HFNO], and NIV alternated with HFNO [NIV + HFNO] may reduce the need for invasive mechanical ventilation (IMV) in patients with COVID-19. The outcome of patients treated non-invasively depends on clinical severity at admission. We assessed the need for IMV according to NIV, HFNO, and NIV + HFNO in patients with COVID-19 according to disease severity and evaluated in-hospital survival rates and hospital and intensive care unit (ICU) lengths of stay...
April 22, 2024: European Journal of Medical Research